willdate

2160 POSTS 0 COMMENTS

ESC 2023: Siemens unveils Acuson Origin imaging platform

Siemens Healthineers has ...

SCAI: FDA panel vote “encouraging” for advance of renal denervation

FDA
The Society for Cardiovas...

Elevate pLVAD completes early feasibility study

Enrolment has been comple...

AI model may improve detection of atrial septal defect

An artificial intelligenc...

STAR-T trial of DrugSorb-ATR completed

CytoSorbents has announce...

Cardiovascular News’ top 10 stories of July 2023

cardiovascular news top 10
Hitting the headlines...

CMS creates new MS-DRG codes and payments for coronary IVL

Shockwave Medical has ann...

CardioPrecision moves into US market

CardioPrecision, a develo...

EACTS puts innovation to the fore

Innovation is a part ...

Michael Jaff joins board of directors at HeartBeam

HeartBeam, developer ...

Clinical trial to compare PCI and CABG in women and minorities

Researchers will carr...

PECA Labs appoints new board members

PECA Labs has added Jeffr...

Gut bacteria linked to coronary atherosclerotic plaques

In a major Swedish st...

Timeline: Key milestones in the paclitaxel story

The release of a letter f...

Key messages from EBC MAIN at three years

EBC MAIN investigator...

Translumina acquires Blue Medical Devices

Translumina has annou...

iTFlow blood flow analysis software gains US FDA approval

The US Food and Drug Admi...

CorWave closes series C funding round

CorWave has raised €61 mi...

US FDA approval for AI TAVI planning software

AI
Dasi Simulations has anno...

ESC appoints Jean-François Riffaud as CEO

The European Society ...

Conformal Medical completes series D financing round

Conformal Medical has...

First TAVI procedures performed using F2 cerebral embolic filter

EnCompass Technologies ha...

Ruggero De Paulis

Inventor of the Valsalva ...

Cardiovascular News – Issue 69 – May 2023: US Edition

In this issue: A new...

EuroPCR 2023: Robocath launches new robotic PCI platform

Robocath has announced th...

Foldax acquires proprietary polymer patent family

Tria
Foldax has announced ...

SavvyWire to be assessed in COMPLETE TAVR substudy

OpSens has announced the ...

Turning extra pulses into pluses

This educational suppleme...

More shocks for rocks

How has the new Shock...

Managing eccentric and nodular calcium with IVL

Calcified nodules are...

The r(evolution) of calcium in Bristol

Tom Johnson (Universi...

US FDA expands indication for Farxiga

AstraZeneca’s Farxiga (da...

CAAS Qardia gains Japanese certification

Pie Medical Imaging has r...

Shockwave Medical completes Neovasc acquisition

Shockwave Medical has...

OpSens completes European enrolment in SAFE-TAVI study

OpSens has announced the ...

Smart glasses guide remote support for pioneering TAVI procedure

The UK’s first remotely-s...

Enrolment target met in ECLIPSE coronary atherectomy trial

Cardiovascular System...

Experts update consensus on left atrial appendage closure

The Society for Cardi...

Azeem Latib joins Supira Medical as medical director

Supira Medical has an...

Medtronic relaunches Harmony transcatheter pulmonary valve

Medtronic has announced t...

Barostim misses primary endpoint in BEAT-HF postmarket trial

CVRx has announced the pr...

US FDA clears tool to rapidly analyse RV/LV ratio

RapidAI announced it has ...

Renal denervation “can reach new shores”

The publication of a ...

Teleflex grows catheter portfolio following US FDA approval

Teleflex Incorporated has...

Xeltis secures funding to progress clinical trials

Xeltis has raised €32 mil...

ACC, AHA and SCAI lay roadmap for interventional cardiology training

The American College of C...

ESC and EAPCI publish renal denervation consensus statement

SonieVie
Renal denervation represe...

Cardiovascular News 68 – February 2023: OUS Edition

In this issue: Medic...

ADVERTORIAL: A step forward in scoring balloon catheter design

This advertorial is spons...

Cardiovascular-aortic community comes together at CX 2023

From cutting-edge aortic ...

Slow progress made on gender balance in cardiovascular trial leadership

Little progress has been ...

Nieves Gonzalo

Interventional cardiology...

Shockwave agrees to acquire Neovasc

Shockwave Medical has...

NICE lowers threshold for statins to prevent cardiovascular events

The UK’s National Institu...

HVR Cardio closes €10.7 million series B funding round

HVR Cardio has closed...

Funding secured to advance development of Pulse IVL system

AVS has announced that it...

Cardiovascular News’ top stories of 2022

Which stories, features a...

SCAI announces recipients of early career grant scheme

The Society for Cardiovas...

First US procedure performed using ShortCut leaflet splitting device

Pi-Cardia has announced t...

Cardiology societies urge rethink of randomised controlled trial design

The current model for ran...

First-in-human procedure performed using Impella RP Flex

The first implant procedu...

Late-breaking Xlimit randomised trial data shared at CSC 2022 congress

Data presented at an inno...

Timothy D Henry

A pioneer of one of the f...

Cardiovascular News 67 – November 2022: OUS Edition

In this issue: Lates...

Cardiovascular News 67 – November 2022: US Edition

In this issue: Lates...

US FDA accepts post-approval study reports for Impella

Abiomed has announced...

MedAlliance to be acquired by Cordis

MedAlliance is to be acqu...

Rates of stroke and embolism lower with apixaban compared to rivaroxaban

In a large, population-ba...

Swedish and Dutch organisations agree to research collaboration

The Uppsala Clinical ...

Latest data underscore optimism for future of renal denervation

Ajay Kirtane (Columbi...

Long-term P2Y12 monotherapy after PCI “may be a promising strategy”

Three-year outcomes from ...

Enrolment completed in trial comparing PCI in diabetic patients

ABILITY DIABETES-GLOBAL, ...

Puzzle Medical wins 2022 TCT Shark Tank innovation competition

Puzzle Medical Devices wa...

First US TAVI procedure performed using SavvyWire guidewire

OpSens has announced that...

Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022

Biotronik has announc...

FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI

Medtronic has received Fo...

Clinical trial of TAVI in severe aortic regurgitation completes enrolment

JenaValve Technology has ...

Medtronic expands US rollout of Evolut FX TAVI system

Medtronic has announced t...

Shockwave initiates all female coronary IVL registry study

Shockwave Medical has ini...

TCT 2022 hears “important data” from renal denervation trials

Findings from the RAD...

TCT 2022: Valentin Fuster receives career achievement award

The major contributio...

US FDA grants 510(k) clearance for SavvyWire TAVI guidewire

OpSens has received 510(k...

Vascade vascular and venous closure devices gain CE mark

Haemonetics Corporati...

Latest Sapien TAVI valve features anti-calcification technology

Edwards Lifesciences has ...

First patient joins study of SSO2 therapy post-PCI

Zoll Medical has announce...

Tom Nguyen

As a proponent of minimal...

Cardiovascular News’ top 10 most popular stories of August 2022

The most read stories fro...

JenaValve raises US$100 Million to advance Trilogy TAVI system

JenaValve Technology has ...

ESC 2022: Risk score predicts mortality for AF patients after TAVI

Researchers have deve...

Cardiovascular News 66 – August 2022: OUS Edition

In this issue: Call ...

AHA and CRF announce collaborative education programme

The American Heart Associ...

Spotlight turns to TAVI in patients with moderate aortic stenosis

Ongoing clinical tria...

Cardiovascular News’ top 10 most popular stories of July 2022

The most read stories fro...

“Worrisome” rise in cardiovascular disease predicted out to 2060

Projected rates of cardio...

VenusP-Valve gains approval from China’s NMPA

VenusP-Valve
The VenusP-Valve (Ven...

SCAI names Sunil Rao as incoming president

Sunil Rao (Duke Unive...

SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”

Analysis of data from a U...

EuroPCR 2022 hears new data on robotic PCI

New data on robotic-assis...

Medtronic gains FDA approval for Onyx Frontier drug-eluting stent

Medtronic has announced t...

Cardiovascular News 65 – May 2022: US Edition

In this issue: New d...

Cardiovascular News 65 – May 2022: OUS Edition

In this issue: New d...

Vijay Kunadian

Vijay Kunadian (Newcastle...

ADVERTORIAL: TAVI valve durability under the microscope

This advertorial is s...

Cardiovascular News’ top 10 most popular stories of April 2022

The most read stories fro...

DCB in PCI: Adjunctive therapy or standard of care?

This educational suppleme...

“TAVI was my baby, now it is a teenager”

In the history of transca...

Health Canada approval granted for SavvyWire TAVI guidewire

OpSens has announced that...

First patient enrolled in EXPAND TAVR II trial

Medtronic has announc...

SCAI issues position paper on transaxillary arterial access

The Society for Cardiovas...

Translumina announces launch of dual drug polymer-free coated stent

Translumina has announced...

Quest International and CathWorks partner to scale up FFRangio

Quest International a...

VenusP-Valve gains CE mark

VenusP-Valve
Venus Medtech's trans...

First patient enrolled in BIOMICS study for CTO-PCI

Biosensors International ...

Corvia announces publication of REDUCE LAP-HF II data

Corvia Medical has an...

Philips launches Ultrasound Workspace at ACC.22

Royal Philips is launchin...

FDA approval granted for Mitris Resilia mitral valve replacement

Edwards Lifesciences has ...

Shockwave coronary IVL gains Japanese approval

Shockwave Medical’s C2 co...

First patient enrolled in PICSO-AMI-V study

Miracor Medical has a...

RADIANCE-II renal denervation trial completes enrolment

Investigators have comple...

Expert group sets out principles for device-led hypertension trials

A consensus document outl...

Women less likely to receive cardiogenic shock treatment

Woman patient
Women are less likely to ...

Putting “stent regret” behind us

Nick West, chief medi...

CSI’s Propel pVAD system gets first-in-human use

Cardiovascular Systems—CS...

Cardiologists without borders

“When I was one year ...

Ryan Egeland joins Big Sky Biomedical

Big Sky Biomedical ha...

Cardiovascular News’ top 10 most popular stories of February 2022

The most read stories fro...

CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI

Two-year findings fro...

CRT 2022 hears results of animal study of Tria TAVI valve

Tria
Results from the firs...

Partnership to promote wearable tech in cardiology trials

Wearable technology and d...

Teleflex catheters and coronary guidewires cleared for CTO PCI

Teleflex has announced th...

New data underpin drive towards earlier AF ablation strategies

Historically, cathete...

On-pump and off-pump CABG confer similar outcomes over 10 years

A 10-year study monitorin...

Heart team approach points to mortality benefit in complex cardiac patients

Consultation by a heart t...

Robert Califf to return as US FDA commissioner

Cardiologist and rese...

Expanded robotic training will benefit cardiovascular care

Robotic systems have the ...

3D printing to support physician training and coronary device testing

The donation of new 3...

Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

Elixir Medical has an...

Boston Scientific closes acquisition of Baylis Medical Company

Boston Scientific has...

MedHub announces investment and pivotal study completion

MedHub has announced the ...

Portsmouth Hospital: How tech is guiding decision-making in the cath lab

Peter Haworth (Portsmouth...

HeartFlow and Longview terminate merger agreement

HeartFlow has announced t...

Second phase of ASCENT ASD trial begins

Atheart Medical has a...

ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases

This advertorial is spons...

Susheel Kodali

Born in India and rai...

Cardiovascular News 64 – February 2022: US Edition

In this issue:  Coro...

Cardiovascular News 64 – February 2022: OUS Edition

In this issue:  Coro...

JIM 2022 moves to June slot

Organisers of the Joint I...

Scoreflex NC PTCA catheter gains FDA premarket approval

Cardiovascular Systems (C...

Gore’s Cardioform Septal Occluder reaches 10-year milestone

WL Gore & Associa...

Pioneering pig to human heart transplant heralded as a breakthrough

A 57-year-old patient wit...

Omicron surge sees STS move 2022 annual meeting online

The Society of Thoracic S...

Robocath completes European study of robot-assisted PCI

Robocath has announced th...

Impella gains a trio of regulatory approvals

Regulators in three count...

Evolut PRO TAVI valve gains approval in China

Medtronic has announc...

Cardiovascular News’ top 10 most popular stories of December 2021

cardiovascular news top 10
The most read stories fro...

FDA clears CavaClear IVC filter removal laser sheath

Royal Philips has ann...

First clinical results for Tria biopolymer valve published

Tria
Foldax has announced ...

Sapien 3 with Alterra prestent gains FDA approval

Sapien 3
Edwards Lifesciences ...

Initial implants of Thubrikar TAVI system to commence

Thubrikar Aortic Valve ha...

AI improves confidence in CAD detection from a stress echocardiogram

Ultromics has announc...

Opsens files 510(k) submission to US FDA for TAVI guidewire

Opsens has filed a 510(k)...

Understanding the risk of acute kidney injury in the cath lab

Huge strides have bee...

Philips expands cardiac ultrasound portfolio

Royal Philips has ann...

Foldax commences clinical study of Tria surgical aortic valve in India

Tria
Foldax has announced that...

Venus Medtech announces Cardiovalve acquisition

Venus Medtech has announc...

SyMap Medical closes US$100 million financing round

SyMap Medical has ann...

Interim REVERSE-IT trial results published in NEJM Evidence

Interim results from ...

Cardiovascular News’ top 10 most popular stories of November 2021

cardiovascular news top 10
Featuring stories from th...

AI-based algorithm could predict outcomes after cardiac surgery

AI
A novel artificial intell...

Mirvat Alasnag

Mirvat Alasnag is the Gul...

First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire

Opsens has announced the ...

First patients enrolled in FAST III study of vFFR-guided PCI

The first patients have b...

What to expect from AHA 2021

Ahead of the American Hea...

ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab

This advertorial is spons...

Ron Waksman joins SIS Medical AG advisory board

SIS Medical AG has ap...

Lessons from SURTAVI

Transcatheter aortic valv...

Cardiovascular News 63 – November 2021: OUS Edition

In this issue:  MAST...

Aktiia announces Series A funding round

Hypertension health-t...

TCT 2021: Studies to highlight patient outcomes with Impella

Results from two studies ...

Bifurcation lesions: Exploring the latest science

This educational suppleme...

AHA and ACC release clinical guidelines for evaluation of chest pain

Joint clinical practice g...

Enrolment completed in study of Teleflex QuikClot device

Teleflex announced the co...

CRF waives cost for digital access to TCT 2021

The Cardiovascular Resear...

Cardiac CTA parameters predict post-TAVI mortality

Cardiac CT angiograph...

First European implants of Trilogy TAVI system completed

JenaValve Technology has ...

Heartflow announces start of REVEALPLAQUE clinical trial

HeartFlow has announced t...

Study charts “inequities” in growth of TAVI in US hospitals

The expansion of transcat...

Clinical study of SavvyWire TAVI guidewire commences

OpSens has announced the ...

FDA monitoring gender differences in outcomes with LAAO devices

The US Food and Drug Admi...

Enrolment completed in study of Tria aortic valve

Tria
Foldax has announced comp...

Siemens launches Luminos Impulse fluoroscopy system

Siemens Healthineers has ...

Abbott’s Amplatzer Talisman gains FDA approval

Abbott has announced that...

Open Stent Solution closes €2.5 funding round

Open Stent Solution (OSS)...

HRX digital health event moved to September 2022

The Heart Rhythm Society ...

Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

CX Aortic Vienna
Capturing the latest deve...

ADVERTORIAL: Optimising TAVI device choice

This advertorial is spons...

Randomised trials needed to evaluate safety and efficacy of TMVR

Randomised trials are...

Abbott receives FDA approval for Portico with FlexNav TAVI system

Abbott has announced ...

TCT 2021: Late-breaking trials programme announced

The Cardiovascular Re...

Christoph Naber

Christoph Naber (Essen, G...

STENTiT makes trio of appointment to its medical advisory board

STENTiT, a medical de...

ABILITY Diabetes Global enrols thousandth patient

Concept Medical has annou...

Digital app speeds up time to STEMI care

“During a heart attac...

Cardiovascular News’ top 10 most popular stories of August 2021

cardiovascular news top 10
August’s top 10 features ...

Second hospital implants Aeson bioprosthetic artificial heart

CARMAT has announced the ...

Medtronic gains FDA approval for its latest-generation TAVI system

Medtronic has announced U...

Cardiovascular News 62 – August 2021: OUS Edition

In this issue: Meta ...

Cardiovascular News 62 – August 2021: US Edition

In this issue: Meta ...

Ten-year outcomes of Yukon DES in diabetic patients published in JAHA

Translumina has announced...

Ultromics completes US$33 million Series B funding round

Ultromics, a developer of...

FDA grants breakthrough device designation to Impella ECP

The US Food and Drug ...

App launched to cut time to treatment for STEMI patients

Physicians at Mount Sinai...

Abbott’s Amplatzer Amulet gains US FDA approval

Abbott has announced ...

Occlutech gains IDE approval for OCCLUFLEX pivotal study

Occlutech Holding has ann...

Women underrepresented in cardiovascular clinical trials

Women remain underreprese...

Realview Imaging gains FDA approval for Holoscope-i system

RealView Imaging has anno...

Back in the room: A welcome return to in-person education

With the COVID-19 pan...

Cardiovascular News’ top 10 most popular stories of July 2021

cardiovascular news top 10
Our top 10 stories of Jul...

Ancora Heart secures US$80 million in financing

Ancora Heart has clos...

HeartFlow announces merger agreement

HeartFlow has entered...

First patients treated with reSept ASD occluder in IDE trial

atHeart Medical has a...

FDA approval for SafeCross transseptal RF system

East End Medical has ...

Common cath lab practices under the microscope in AHA review

The American Heart As...

Cardiovascular News’ top 10 most popular stories of June 2021

cardiovascular news top 10
Our top 10 stories of Jun...

Royal Philips announces start of DEFINE GPS study

Philips iFR Coregistration SyncVision
Royal Philips has ann...

Registry DAPT data “could support clinical trials”

Data captured in the ...

Cindy Grines

Cindy Grines is an interv...

Shockwave’s coronary IVL device gains TPT payment approval

Shockwave Medical has ann...

Delaying CABG after AMI may not improve outcomes

A study looking at the ti...

Neurescue’s aortic occlusion device gains US FDA approval

Neurescue has announced t...

GE Healthcare and ACC partner to advance AI in cardiology

GE Healthcare is collabor...

Medtronic stops sale of its HVAD system

Medtronic is stopping...

Abiomed acquires breakthrough device company preCARDIA

Abiomed has acquired preC...

MDR comes into effect across EU

The European Union (EU) M...

First-in-human use of Tria biopolymer heart valve completed

Tria
Foldax has announced the ...

RE-ACCESS study has implications for TAVI valve selection

This advertorial is spons...

TricValve transcatheter bicaval valve system receives CE mark

OrbusNeich and P&F Pr...

Leaflex: Changing the conversation around aortic stenosis?

This advertorial is spons...

Preventing kidney damage in the cath lab

This advertorial is spons...

ACC.21: App speeds up time to PCI for STEMI patients

ST-elevation myocardial i...

SCAI names Timothy Henry as president

Timothy D Henry (The ...

SCAI updates consensus guidelines on cath lab standards

The Society for Cardiovas...

CE mark for BACE device for functional mitral regurgitation

Phoenix Cardiac Devices h...

Researchers create heart replicas from CT images

Researchers from King's C...

AcQCross transseptal crossing devices gain US FDA clearance

Acutus Medical has announ...

First procedure performed in SMART head-to-head TAVI study

The first procedure h...

Next generation TriClip gains CE mark approval

Abbott has received CE ma...

Cardiovascular News’ top 10 most popular stories of March 2021

cardiovascular news top 10
Our top 10 stories of Mar...

Xience stent receives CE mark for short duration DAPT

Abbott has announced ...

Dipti Itchhaporia begins term as ACC president

Dipti Itchhaporia has...

Randomised trial data supports use of the PleuraFlow system

ClearFlow has announced c...

One in three female cardiologists report unwanted advances

More than a third of fema...

Shockwave Medical to bring IVL to the Chinese market

Shockwave Medical has ann...

Mavacamten granted US FDA new drug application

Bristol Myers Squibb has ...

Stephan Achenbach

Stephan Achenbach is prof...

Approval allows use of single access Impella procedure across Europe

Following consultation wi...

ControlRad Select imaging system gains FDA market clearance

ControlRad has announ...

ACC.21 switches to a virtual-only meeting

The American College of C...

Urgent action needed to address growing burden of heart failure

Urgent action is need...

OpSens gains CE mark for OptoWire III

OpSens has received CE ma...

What role will remote robotic procedures play in the future of PCI?

With the COVID-19 pan...

Teleflex completes enrolment in CTO-PCI IDE study

Teleflex has announced th...

Global heart failure cases soar since 1990

The number of patients wi...

Robotic treatment starts with the heart

Robotic-assisted treatmen...

STS 2021: Sean C Grondin elected STS president

Cardiothoracic surgeon Se...

STS 2021: Study identifies significant gender disparities in CABG

Women are significantly l...

STS 2021: Cardiothoracic surgery suffers due to COVID-19

The COVID-19 pandemic...

STS 2021: Study of Impella 5.5 reports 79% survival rate at explant

A study of 356 patients t...

Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI

An analysis of data from ...

Ancora Heart enrols first patient in the CORCINCH-HF study

Ancora Heart has anno...

Study backs biopolymer used in Foldax’s Tria valve

Tria
Foldax has today anno...

Aktiia’s wrist-mounted blood pressure monitor gains CE mark

Aktiia has announced ...

Social determinants key in assessing coronary heart disease risk

A patient’s risk of c...

Patients “fearful” of seeking cardiac care during pandemic

Analysis of data from Eng...

Diamondback 360 atherectomy system gains CE mark

Cardiovascular System...

Elixir Medical announces treatment of first patient in BIOADAPTOR trial

Elixir Medical, a develop...

ACC.21 to offer remote COVID-19 screening

The American College of C...

Ultromics receives FDA clearance for EchoGo Pro

The US Food and Drug ...

CorWave secures €35 million investment

CorWave has rasied €35 mi...

ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?

This advertorial is spons...

Jian’an Wang named as editor of JACC: Asia

Jian’an Wang (Heart Cente...

Abiomed completes first stage in early feasibility study of ECP heart pump

Abiomed has announced tha...

CardioFlux imaging system granted Breakthough Device Designation

Genetesis has announced t...

LivaNova reaches agreement to sell its heart valve business

LivaNova has entered ...

Cathy Gates named as ACC’s new CEO

Cathy Gates has been ...

Cardiothoracic surgery “stifled” during COVID-19 pandemic

Reduced effectiveness of ...

Scoring system stratifies “dual” risk in aortic stenosis patients

A study published in the ...

Women face a higher risk of heart failure after STEMI

Woman patient
Women face a 20% increase...

Tributes paid following death of esteemed UK cardiologist Anthony Gershlick

University of Leicester a...

3D-printed heart model could be used in preparation for surgical training

A study published in ACS ...

Corvia completes randomisation in REDUCE LAP-HF II trial

Corvia has announced ...

Boston Scientific discontinues Lotus Edge TAVI device

Boston Scientific has...

Michael Reardon

A pioneer in the field of...

Results from Onyx One Clear study published

Results of the Onyx O...

First 1,000 patients treated with Impella 5.5 with SmartAssist

Abiomed has announced tha...

AstraZeneca receives EU approval for heart failure drug Forxiga

AstraZeneca’s Forxiga (da...

Recipients of MyoSeed research funding announced

MyoKardia has announced t...

The benefits of optical coherence tomography in the cath lab

Kevin Croce, director...

Late-breaking science is alive and well despite the pandemic

Late-breaking science in ...

First patients treated with the Impella ECP heart pump

Abiomed has announced the...

Panel explores the unanswered questions around short duration DAPT

Mounting evidence ove...